Reversible inactivation of the transcriptional function of P53 protein by farnesylation
2006

Controlling p53 Function with Farnesylation

publication Evidence: moderate

Author Information

Author(s): Couderc Bettina, Penary Marie, Tohfe Mustapha, Pradines Anne, Casteignau Antoine, Berg Danièle, Favre Gilles

Primary Institution: INSERM U563, Institut Claudius Regaud, Toulouse, France

Hypothesis

Can the function of the p53 protein be controlled by its localization through farnesylation?

Conclusion

Farnesylation of p53 impairs its transcriptional activity, but this can be restored by inhibiting farnesyl transferase.

Supporting Evidence

  • Farnesylation of p53 leads to its localization in the cytosol, rendering it non-functional.
  • Inhibition of farnesyl transferase allows p53 to translocate to the nucleus and regain its activity.
  • The study demonstrates a novel method to control protein function through post-translational modifications.

Takeaway

Scientists found a way to control a protein called p53, which helps stop cancer, by changing where it is in the cell. If they block a certain process, they can make it work again.

Methodology

The study involved constructing adenoviral vectors to express chimeric p53 proteins and testing their effects on human osteosarcoma cells.

Limitations

The study primarily focused on a specific cell line and may not fully represent other cell types or conditions.

Participant Demographics

The study used human osteosarcoma p53-/- cell line (SaOs-2).

Digital Object Identifier (DOI)

10.1186/1472-6750-6-26

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication